Table 4.
TOS and TAS of OLE and PTX IC50 doses, and combinations formed at different percentages in MCF-7 cells.
| Groups | TOS (µmol/L) | TAS (µmol/L) |
|---|---|---|
| Control | 33.33 ± 4.20 | 650 ± 50 |
| OLE IC50 | 6.11 ± 1.11**** | 2783.3 ± 16.67**** |
| PTX IC50 | 10.00 ± 0.97**** | 1066.7 ± 101.4*** |
| 10% | 6.67 ± 0.96**** | 1566.7 ± 120.2**** |
| 20% | 5.56 ± 1.47**** | 2200 ± 115.5**** |
| 30% | 3.33 ± 0.96**** | 2716.7 ± 60.09**** |
| 40% | 13.33 ± 2.54*** | 2216.6 ± 116.7**** |
Note: ***p < 0.001, ****p < 0.0001 when compared with the control. The results are shown as mean ± SEM of three experiments (n = 3).